Switch to
More onapp

Piramal Pharma Ltd

PPLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,829 cr, stock is ranked 262
High RiskStock is 3.53x as volatile as Nifty
133.600.95 (+0.72%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,829 cr, stock is ranked 262
High RiskStock is 3.53x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
42.10
PB RatioPB Ratio
2.36
Dividend YieldDiv. Yield
Sector PESector PE
35.69
Sector PBSector PB
4.33
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Piramal Pharma Limited is an India-based company, which offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities. The Company has approximately 15 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business, and the India consumer healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to generic companies. PCC's complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anesthetics, injectable anti-infectives, and other therapies.

Financial TrendFinancial statements 

202120226.546.890.840.38
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 22, 2022

Piramal Pharma Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Piramal Pharma Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 11, 2022

Piramal Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Piramal Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Recording of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 9, 2022

Piramal Pharma Limited has informed the Exchange about Audio Recording of Analysts/Institutional Investor Meet/Con. Call | Download

Piramal Pharma Limited has informed the Exchange about Audio Recording of Analysts/Institutional Investor Meet/Con. Call | Download

See all events